Comparison

Medicarpin European Partner

Item no. TMO-TN1918-1mg
Manufacturer TargetMol
CASRN 32383-76-9
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 100.00%
Citations Effect of lead treatment on medicarpin accumulation and on the gene expression of key enzymes involved in medicarpin biosynthesis in Medicago sativa L.Environ Sci Pollut Res Int. 2014 Dec;21(24):14091-8.
Smiles [H][C@@]12COc3cc(O)ccc3[C@]1([H])Oc1cc(OC)ccc21
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 32383-76-9
Shipping Condition Cool pack
Available
Manufacturer - Targets
ROS|||JNK|||Apoptosis|||Bcl-2 Family
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
270.28
Description
N-Methylnicotinamide is one of the endogenous metabolites that ameliorates endothelial dysfunction.
Pathways
Apoptosis|||MAPK|||Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close